Aescia

“A continuous-care platform for structured patient follow-up and specialty-clinic workflow. Aescia for Hospitals is an investigational Software as a Medical Device in clinical evaluation through the SAFE-Discharge trial at Royal Prince Alfred Hospital. Aescia for Clinics is a workflow platform for specialty clinics.”

Products & services

Questions & answers

What is Aescia?

“Aescia is a continuous-care platform for the weeks between a high-acuity discharge and the next clinical appointment. It is a privately held healthtech company with operations in Sydney, Australia and Montréal, Canada.”

Who founded Aescia?

“Aescia was founded by James Kurrle, a hospital doctor with critical care experience who trained and practised across rural and metropolitan New South Wales (Wagga Wagga and Sydney), and Vasken Dermardiros, a machine-learning PhD from Concordia University. James is the Chief Executive Officer and authors the clinical pathway engine.”

Where does Aescia operate?

“Aescia operates from Sydney, Australia and Montréal, Canada. 9550-0708 Québec inc. (NEQ 1181312316) holds the platform intellectual property and does the research and development. Aescia Pty Ltd (ABN 96 687 840 517) operates in Australia and New Zealand and is the Australian regulatory applicant.”

Data formats & record details

Download this profile and inspect its supporting evidence.

Entity ID
urn:readyscan:entity:aescia-q139559566
Material fingerprint
fnv1a64:625376ee00a267c6
Entity revision
fnv1a64:6640ad0e7912d323
Published
2026-10-27
Modified
2026-10-27
Source summary
Aescia Health: “A continuous-care platform for structured patient follow-up and specialty-clinic workflow. Aescia for Hospitals is an investigational Software as a Medical Device in clinical evaluation through the SAFE-Discharge trial at Royal Prince Alfred Hospital. Aescia for Clinics is a workflow platform for specialty clinics.”